Abstract:Objective To observe and compare the change of urinary neutrophil gelatinase- associated lipocalin(NGAL)in patients with chronic kidney disease(CKD) so as to explore the clinical significance of urinary NGAL in CKD. Methods A total of 82 CKD patients who received renal biopsy in Ruijin Hospital from March 2012 to December 2012 were enrolled. Urine samples were collected before renal biopsy. The level of urinary NGAL was measured by ELISA. The levels of serum and urinary creatinine, and urinary NAG enzyme activity were measured by automatic biochemical analyzer. The levels of urinary β2-microglobulin, urinary retinol binding protein, urinary α1-microglobulin, urinary transferrin and urinary immunoglobulin G were measured by urine protein electrophoresis. We presented the measurement data of the normal distribution with x ±s, and used t test to compare two groups. On the other hand, we presented the measurement data of non-normal distribution with four-digit(P75, minimum-maximum), and adopted Mann-Whitney test to compare the two groups. The correlation analysis between groups was performed by Pearson method. Statistical significance was considered when the P value was less than 0.05. Results No statistical significance was found between the level of urinary NGAL in the CKD patients and that of the healthy controls [0.36(0-33.58)ng/ml vs 0.23(0-0.39)ng/ml,P=0.65]. The level of urinary NGALs was statistically significantly increased in the patients with diabetic nephropathy(U=30, P=0.04), tubulointerstitial nephritis(U=37, P=0.01)or the patients with CKD stage 3(U=204, P=0.00). In patients with diabetic nephropathy, urinary NGAL level positively correlated with urine α-1-microglobulin level(r=0.99, P=0.02). Meanwhile, the 24-hour urine protein(U=247, P=0.00), microalbuminuria(U=330, P=0.00), urine tranferrin(U=351, P=0.01), urinary immunoglobulin G(U=278, P=0.00), urinary α1- microglobulin(U=231, P=0.00)and urinary N-acetyl-beta-D-glucosaminidase(NAG) enzyme activity(t=3.04, P=0.00)were much higher in patients with elevated urinary NGAL than in patients with normal urinary NGAL. Conclusion In patients with chronic kidney disease,the level of urinary NGAL may reflect not only the tubular function injury, but, to a certain extent, the glomeruli damage as well.

A Novel Biomarker in Differentiating MCN and MN: Urinary sCD80

Diagnostic potential of urinary monocyte chemoattractant protein-1 for Alzheimer's disease and amnestic mild cognitive impairment

Urinary Soluble CD163 Levels Predict IgA Nephropathy Remission Status

Urinary and plasma proteomics to discover biomarkers for diagnosing between diabetic nephropathy and minimal change nephrotic syndrome or membranous nephropathy

Pathological Significance of a Panel of Urinary Biomarkers in Patients with Drug-Induced Tubulointerstitial Nephritis.

The significance of urinary neutrophil gelatinase-associated lipocalin in the early diagnosis of diabetic nephropathy

Urinary neutrophil gelatinase-associated lipocalin: A potential biomarker for predicting rapid progression of drug-induced chronic tubulointerstitial nephritis.

Clinical Significance of Determination of Serum Cystatin C,lipoprotein (α) and High Sensitivity C-reactive Protein in Type 2 Diabetic Patients with Early Renal Impairment.

The Application of Podocyte Antigen PLA2R and Anti-Pla2r Antibody in the Diagnosis and Treatment of Membranous Nephropathy

A New Model for the Discrimination Between Ulcerative Colitis and Crohn's Disease.

Identification of biomarkers related to immune and inflammation in membranous nephropathy: comprehensive bioinformatic analysis and validation

A noninvasive method of diagnosing membranous nephropathy using exosomes derived from urine

Diagnostic potential of urinary monocyte chemoattractant protein‐1 for Alzheimer’s disease and amnestic mild cognitive impairment

Evaluating new biomarkers for diabetic nephropathy: Role of α2-macroglobulin, podocalyxin, α-L-fucosidase, retinol-binding protein-4, and cystatin C

Urinary single-cell sequence analysis of the urinary macrophage in different outcomes of membranous nephropathy

Novel Biomarkers in Membranous Nephropathy

Establishment of a novel nomogram for the clinically diagnostic prediction of minimal change disease, −a common cause of nephrotic syndrome

Response Predictors to Calcineurin Inhibitors in Patients with Primary Membranous Nephropathy

Clinical significance of urinary neutrophil gelatinase-associated lipocalin in chronic kidney disease

The detection of aberrantly glycosylated serum IgA1 in minimal change nephrotic syndrome with mesangial IgA deposition patients

Exploration of Early Assessment of Renal Impairment in Multiple Myeloma